Combination immunotherapy of chlorogenic acid liposomes modified with sialic acid and PD-1 blockers effectively enhances the anti-tumor immune response and therapeutic effects

Melanoma is one of the most common malignant tumors. The anti-PD-1 antibody is used for the treatment of metastatic melanoma. Treatment success is only 35-40% and a range of immune-related adverse reactions can occur. Combination of anti-PD1 antibody therapy with other oncology therapies has been at...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Xixi Li (Автор), Shunyao Zhu (Автор), Ping Yin (Автор), Shuangshuang Zhang (Автор), Juewen Xu (Автор), Qin Zhang (Автор), Senlin Shi (Автор), Ting Zhang (Автор)
Формат:
Опубликовано: Taylor & Francis Group, 2021-01-01T00:00:00Z.
Предметы:
Online-ссылка:Connect to this object online.
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Internet

Connect to this object online.

3rd Floor Main Library

Подробно о фондах из 3rd Floor Main Library
Шифр: A1234.567
Копировать 1 Доступно